Suchergebnisse - "Vlachopoulos, Charalambos"

PubPharm (40)

1

Impaired cerebral autoregulation in Fabry disease : A case-control study

enthalten in: Journal of neuroimaging : official journal of the American Society of Neuroimaging | 2023

von Palaiodimou, L. | Papagiannopoulou, G. | Bakola, E. | +12

2

Blood pressure variability : methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper ∗

enthalten in: Journal of hypertension | 2023

von Parati, G. | Bilo, G. | Kollias, A. | +37

3

A randomized clinical trial of lipid metabolism modulation with fenofibrate for acute coronavirus disease 2019

enthalten in: Nature metabolism | 2022

von Chirinos, J. | Lopez-Jaramillo, P. | Giamarellos-Bourboulis, E. | +59

UpdateOf: Res Sq. 2022 Aug 10;:. - PMID 35982675

4

Clusters of risk factors in metabolic syndrome and their influence on central blood pressure in a global study

enthalten in: Scientific reports | 2022

von Laucyte-Cibulskiene, A. | Chen, C. | Cockroft, J. | +21

5

Twenty-Four-Hour Central (Aortic) Systolic Blood Pressure : Reference Values and Dipping Patterns in Untreated Individuals

enthalten in: Hypertension (Dallas, Tex. : 1979) | 2022

von Weber, T. | Protogerou, A. | Agharazii, M. | +34

6

Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19

enthalten in: Scientific reports | 2021

von Stamatelopoulos, K. | Georgiopoulos, G. | Baker, K. | +72

7

EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care : the DA VINCI study

enthalten in: European journal of preventive cardiology | 2021

von Ray, K. | Molemans, B. | Schoonen, W. | +28

8

Vascular consequences of inflammation : a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society

enthalten in: Journal of hypertension | 2020

von Zanoli, L. | Briet, M. | Empana, J. | +12

CommentIn: J Hypertens. 2020 Sep;38(9):1701-1702. - PMID 32769685

9

Eligibility for PCSK-9 inhibitors treatment in acute coronary syndrome, chronic coronary artery disease and outpatient dyslipidemic patients

enthalten in: Atherosclerosis | 2020

von Vlachopoulos, C. | Dima, I. | Soulis, D. | +6

10

Periodontitis and cardiovascular diseases : Consensus report

enthalten in: Journal of clinical periodontology | 2020

von Sanz, M. | Marco Del Castillo, A. | Jepsen, S. | +18